Notable Call Options Activity in BioMimetic Therapeutics

Shares of BioMimetic Therapeutics BMTI are higher on the session by 6.60%, currently trading at $3.07. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are focusing on calls today. A short while ago the October 2011 $5.00 call traded 1,200 times on open interest of 51 contracts. Calls are outpacing puts today 21 to 1. BioMimetic Therapeutics, Inc. is a biotechnology company, which develops and commercializes products to help stimulate the body's natural tissue regenerative process.